Triggering antitumoural drug release and gene expression by magnetic hyperthermia

Adv Drug Deliv Rev. 2019 Jan 1:138:326-343. doi: 10.1016/j.addr.2018.10.004. Epub 2018 Oct 17.

Abstract

Magnetic nanoparticles (MNPs) are promising tools for a wide array of biomedical applications. One of their most outstanding properties is the ability to generate heat when exposed to alternating magnetic fields, usually exploited in magnetic hyperthermia therapy of cancer. In this contribution, we provide a critical review of the use of MNPs and magnetic hyperthermia as drug release and gene expression triggers for cancer therapy. Several strategies for the release of chemotherapeutic drugs from thermo-responsive matrices are discussed, providing representative examples of their application at different levels (from proof of concept to in vivo applications). The potential of magnetic hyperthermia to promote in situ expression of therapeutic genes using vectors that contain heat-responsive promoters is also reviewed in the context of cancer gene therapy.

Keywords: Cancer; Gene therapy; Hydrogel; Liposomes; Magnetic nanoparticles; Polymer; Switchable gates.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Drug Liberation
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Hyperthermia, Induced*
  • Magnetic Fields
  • Neoplasms / genetics*
  • Neoplasms / therapy*
  • Temperature

Substances

  • Antineoplastic Agents